期刊文献+

复方川芎嗪胶囊干预氯吡格雷抵抗的临床研究 被引量:4

下载PDF
导出
摘要 目的评价复方川芎嗪胶囊对氯吡格雷抵抗患者的干预效果。方法采用比浊法测定血小板聚集率,将氯吡格雷抵抗患者68例随机分为两组,氯吡格雷加复方川芎嗪胶囊组及单服氯吡格雷组,每组34例。干预2周后分别复查血小板聚集率。结果干预后氯吡格雷加复方川芎嗪胶囊组二磷酸腺苷(ADP)诱导的血小板聚集率为29.23%,较干预前37.78%下降9.58%(P<0.01);而单用氯吡格雷组干预前后无明显变化(P>0.05)。结论复方川芎嗪胶囊可以增强患者对氯吡格雷的敏感性,降低氯吡格雷抵抗,两药有协同抑制血小板聚集作用。
出处 《中西医结合心脑血管病杂志》 2013年第9期1073-1074,共2页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
  • 相关文献

参考文献7

  • 1Savi P,Pereillo JM,Uzabiaga MF,et al. Identification and biologi- cal activity of the active metabolite of clopidogrel[J]. Thromb Haemost,2000,84(5) :891 - 896.
  • 2Paul A, Bliden KP, Hiatt BI, et al. Clopidogrel for coronary stent ing;Response variability,drug resist, and the effect o pretreatment platelet reactivity [J]. Circulation,2008,107:2908- 2913.
  • 3谭丽玲,贾三庆,王明生,李虹伟,王雷,赵敏,沈潞华,贾宁,孙志军.急性冠脉综合征患者氯吡格雷抵抗的影响因素[J].中国心血管病研究,2006,4(9):680-682. 被引量:14
  • 4Jarvis B, Simpson K. Clopidogrel: A review of its use in the preven- tion of atherothromhosis [J]. Drugs,2000,60:347 - 377.
  • 5Fontana P,Gaussem P,Aiach M,et al. P2Y]2 H2 haplotype is as- sociated with peripheral arterial disease: A case - control study [J]. Circulation, 2003,10 (24) : 2971 - 2973.
  • 6陈可冀,李连达,翁维良.血瘀证与活血化瘀研究[J].中西医结合心脑血管病杂志,2005,3(1):1-2. 被引量:241
  • 7严威,吴小盈,孙红,李灿东,陈慧.氯吡格雷抵抗与血瘀证关系分析[J].江西中医学院学报,2009,21(5):63-65. 被引量:7

二级参考文献22

  • 1陈可冀,李连达,翁维良.血瘀证与活血化瘀研究[J].中西医结合心脑血管病杂志,2005,3(1):1-2. 被引量:241
  • 2郑少平,徐秀英.氯吡格雷抵抗[J].基础医学与临床,2006,26(11):1270-1275. 被引量:1
  • 3李俭强,杨树森,樊瑛,常惠颖.氯吡格雷抵抗——不可忽视的临床问题[J].中国介入心脏病学杂志,2007,15(1):52-55. 被引量:4
  • 4张仁岗,张军平.阿司匹林抵抗的产生机制与防治策略[J].中西医结合学报,2007,5(3):259-262. 被引量:9
  • 5Gurbel PA,Bliden KP,Hiatt BL,et all Clopidogrel for coronary stenting: Response varisbility, drug resistance, and the effect of pretreatment platelet reactivity[ J]. Circulation ,2003,107:2 908 - 2 913.
  • 6Lau WC, Waskell LA, Watkins PB, et al. Atorvastatin redueesthe ability of clopidogrel to inhibit platelet aggregation : a new drug - drug interactionl Circulation ,2003,107:32 - 37.
  • 7Fontana P, Dupont A, Gandrille S,et al. Adenosine diphos-phate-induced platelet aggregation is associated with P2YI2 gene sequence variations in healthy subjectsl Circulation,2003,108:989 - 995.
  • 8LauWC, Gurbel PA, Watkins P.B, et al. Contribution of hepatic cytochrome 17450 3A4 metabolic activity to the phenomenon of clopidogrel resistance. Circulation ,2004,109 : 166 - 171.
  • 9Hechler B, Zhang Y, Eckly A,et al. Lineage-specific over-expression of the P2Y1 receptor induces platelct hyper-reactivity in transgenic mice. J Thromb Haemost,2003,1 : 155 - 163.
  • 10Fontana P,Gaussem P,AiachM,et al. P2YI2 H2 haplo type is associated with peripheral arterial disease:a case-control study. Circulation ,2003,108:2 971 - 2 973.

共引文献258

同被引文献79

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部